Simultaneous quantitative analysis of the antimalarials pyrimethamine and sulfamethoxypyrazine in plasma samples using liquid chromatography/tandem mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 20, Issue 19, 2006, Pages 2947-2953

  Storme, Michael L ^a   Jansen, F Herwig ^b   Goeteyn, Wim ^a   Van Bocxlaer, Jan F ^a  

^a GHENT UNIVERSITY   (Belgium)

^b Dafra Pharma International   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; LIQUID CHROMATOGRAPHY; PATIENT MONITORING; PATIENT TREATMENT;

LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; PLASMA SAMPLES; PYRIMETHAMINE; QUANTITATIVE TOOL; RELATIVE STANDARDS DEVIATIONS; SAMPLE CLEAN-UP; SIMPLE++; SIMULTANEOUS DETERMINATIONS; TURNOVER TIME;

MASS SPECTROMETRY;

EID: 33749507366     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.2670     Document Type: Article

References (21)

1. Dua VK, Sarin R, Gupta NC, Sharma VP. J. Chromatogr. B 1998; 714: 390.
2. Adam I, Osman ME, Elghzali G, Ahmed GI, Gustafssons LL, Elbashir MI. Ann. Trop. Med. Parasit. 2004; 98: 661.
3. Sinnaeve BA, Decaestecker TN, Risha PG, Remon JP, Vervaet C, Van Bocxlaer JF. J. Chromatogr. A 2005; 1076: 97.
4. Risha PG, Shewiyo D, Msami A, Masuki G, Vergote G, Vervaet C, Remon JP. Trop. Med. Int. Health 2002; 7: 701.
5. Amin AA, Snow RW. Malaria J. 2005; 4: 36.
6. Devriendt A, Jansen FH, Weemaes I. Eur. J. Clin. Pharmacol. 1970; 3: 36.
7. Green MD, Mount DL, Nettey H. J. Chromatogr. B 2002; 767: 159.
8. Astier H, Renard C, Cheminel V, Soares O, Mouier C, Peyron F, Chaulet JF. J. Chromatogr. B 1997; 698: 217.
9. Edstein MD. J. Chromatogr 1984; 305: 502.
10. Edstein MD. Chemotherapy 1987; 33: 229.
11. Midskov C. J. Chromatogr. 1984; 308: 217.
12. Bergqvist Y, Eriksson M. Trans. R. Soc. Trop. Med. Hyg. 1985; 79: 297.
13. Bergqvist Y, Eckerbom S, Larsson H, Malekzadeh M. J. Chromatogr. 1991; 571: 169.
14. Eljaschewitsch J, Padberg J, Schürmann D, Ruf B. Ther. Drug Monit. 1996; 18: 592.
15. Johannessen JK, Christiansen I, Schmidt DR, Petersen E, Hansen SH. J. Pharm. Biomed. Anal. 2005; 36: 1093.
16. Dau K, Sarin R. J. Chromatogr. 1991; 563: 333.
17. Taylor J. Clin. Biochem. 2005; 38: 328.
18. Guidance for Industry. Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration, May 2001.
19. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Anal. Chem. 2003; 75: 3019.
20. Berzas Nevado JJ, Castañeda Peñalvo G, Guzmán Bernardo FJ. J. Chromatogr. A 2000; 870: 169.
21. Minzi OMS, Massele AY, Gustafsson LL, Ericson Ö. J. Chromatogr. B 2005; 814: 179.